{
    "id": "192a675b-c93a-439d-a83d-dcb90ce2e2a0",
    "indications": {
        "text": "pilocarpine hydrochloride tablets , usp indicated 1 ) treatment symptoms dry mouth salivary gland hypofunction caused radiotherapy cancer head neck ; 2 ) treatment symptoms dry mouth patients sjogren 's syndrome .",
        "doid_entities": [
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "regardless indication , starting dose patients moderate hepatic impairment 5 mg twice daily , followed adjustment based therapeutic response tolerability . patients mild hepatic insufficiency require reductions . pilocarpine patients severe hepatic insufficiency recommended . needed , refer hepatic insufficiency subsection section label definitions mild , moderate severe hepatic impairment .",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe hepatic impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            },
            {
                "disease": "severe hepatic insufficiency",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_95409"
            }
        ]
    },
    "warningsAndPrecautions": "pilocarpine hydrochloride tablets usp , 5 mg white , film coated , round tablets , debossed lan one side 1313 side . tablet contains 5 mg pilocarpine hydrochloride . supplied follows : bottles 100 ; ndc : 63629-2099-1 store 20\u00b0- 25\u00b0c ( 68\u00b0-77\u00b0f ) [ usp controlled room temperature ] . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "pilocarpine hydrochloride tablets contraindicated patients uncontrolled asthma , known hypersensitivity pilocarpine , miosis undesirable , e.g . , acute iritis narrow-angle ( angle closure ) glaucoma .",
    "ingredients": [
        {
            "name": "PILOCARPINE HYDROCHLORIDE",
            "code": "0WW6D218XJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_141029"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        }
    ],
    "organization": "Bryant Ranch Prepack",
    "name": "Pilocarpine Hydrochloride",
    "effectiveTime": "20240322",
    "indications_original": "Pilocarpine hydrochloride tablets, USP\u00a0are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with Sjogren's syndrome.",
    "contraindications_original": "Regardless of the indication, the starting dose in patients with moderate hepatic impairment should be 5 mg twice daily, followed by adjustment based on therapeutic response and tolerability. Patients with mild hepatic insufficiency do not require dosage reductions. The use of pilocarpine in patients with severe hepatic insufficiency is not recommended. If needed, refer to the \n                        Hepatic Insufficiency\n                      subsection of the\u00a0\n                        Precautions\n                      section of this label for definitions of mild, moderate and severe hepatic impairment.",
    "warningsAndPrecautions_original": "Pilocarpine hydrochloride tablets USP, 5 mg are white, film coated, round tablets, debossed LAN on one side and 1313 on the other side. Each tablet contains 5 mg pilocarpine hydrochloride. They are supplied as follows:\n                  Bottles of 100;\u00a0NDC: 63629-2099-1\u00a0\n                  \n                  \n                     Store at 20\u00b0- 25\u00b0C(68\u00b0-77\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  \n                     Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.",
    "drug": [
        {
            "name": "Pilocarpine Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_141029"
        }
    ]
}